| 1 |
P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis", Nature, Vol. 473, No. 7347, pp. 317-325, May 2011.
DOI
|
| 2 |
F. Schaftenaar, V. Frodermann, J. Kuiper, and E. Lutgens. "Atherosclerosis: the interplay between lipids and immune cells", Current Opinion in Lipidology, Vol. 27, No. 3, pp. 209-215, Jun. 2016.
DOI
|
| 3 |
S. J. Rho, H. M. Lee, and K. W. Oh, "Prevalence of hypercholesterolemia among adults over 30 years old in Korea, 2009-2013", Public Health Weekly Report, Vol. 8, No. 36, pp. 857-860, Sep. 2015.
|
| 4 |
K. Isoda, S. Sawada, M. Ayaori, T. Matsuki, R. Horai, Y. Kagata, K. Miyazaki, and et al. "Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice", The Journal of Biological Chemistry, Vol. 280, No. 8, pp. 7002-7009, Feb. 2005.
DOI
|
| 5 |
K. L. Ma, X. Z. Ruan, S. H. Powis, Y. Chen, J. F. Moorhead, and Z. Varghese, "Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice", Hepatology, Vol. 48, No. 3, pp. 770-781, Sep. 2008.
DOI
|
| 6 |
S. M. Grundy, "Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate", Cell Metabolism, Vol. 23, No. 5, pp. 755-757, May 2016.
DOI
|
| 7 |
Y. Gui, S. Yao, H. Yan, L. Hu, C. Yu, F. Gao, and et al. "A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice." Cardiovascular Research, Vol. 102, No. 1, pp. 502-514, Oct. 2016.
|
| 8 |
T. R. Pedersen, "The Success Story of LDL Cholesterol Lowering", Circulation Research, Vol. 118, No. 4, pp. 721-731, Feb. 2016.
DOI
|
| 9 |
Y. A. Kim, "Status of cholesterol level among adults in Korea, 2008-2011", Public Health Weekly Report, Vol. 7, No. 35, pp. 773-776, Aug. 2014.
|
| 10 |
S. L. Pinkosky, R. S. Newton, E. A. Day, R. J. Ford, S. Lhotak, R. C. Austin, and et al, "Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.", Nature Communications, Vol. 7, pp. 13457, Nov. 2016.
DOI
|
| 11 |
J. S. Lee, S. H. Bok, Y. B. Park, M. K. Lee, and M. S. Choi, "4-hydroxycinnamate lowers plasma and hepatic lipids without changing antioxidant enzyme activities", Annals of Nutrition and Metabolism, Vol. 47, No. 3-4, pp. 144-151, May 2003.
DOI
|
| 12 |
Y. Matsuzawa, "Therapy insight: adipocytokines in metabolic syndrome and related ardiovascular disease", Nature Clinical Practice Cardiovascular Medicine, Vol. 3, No. 1, pp. 35-42, Jan. 2006.
DOI
|
| 13 |
I. N. Holcomb, R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, and et al. "FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family", The EMBO Journal, Vol. 19, No. 15, pp. 4046-4055, Aug. 2000.
DOI
|
| 14 |
X. Teng, D. Li, H. C. Champion, and R. A. Johns, "FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties", Circulation Research, Vol. 92, No. 10, pp. 1065-1067, May 2003.
DOI
|
| 15 |
M. R. Lee, D. Shim, J. Yoon, H. S. Jang, S. W. Oh, S. H. Suh, and et al. "Retnla overexpression attenuates allergic inflammation of the airway", PLoS One, Vol. 9, No. 10, pp. e102666, Nov. 2014.
DOI
|
| 16 |
A. Munitz, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg, "Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation", Vol. 182, No. 4, pp. 2357-2363, Feb. 2009.
DOI
|
| 17 |
R. A. Johns, E. Takimoto, L. W. Meuchel, E. Elsaigh, A. Zhang, N. M. Heller, and et al. "Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages", Journal of Leukocyte Biology, Vol. 36, No. 1, pp. 124-144, Jan. 2016.
|
| 18 |
M. R. Lee, C. J. Lim, Y. H. Lee, J. G. Park, S. K. Sonn, M. N. Lee, and et al. "The adipokine Retnla modulates cholesterol homeostasis in hyperlipidemic mice", Nature Communications, Vol. 5, pp. 4410, Jul. 2014.
DOI
|
| 19 |
B. Blagoev, I. Kratchmarova, M. M. Nielsen, M. M. Fernandez, J. Voldby, J. S. Andersen, and et al. "Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature", The Journal of Biological Chemistry. Vol. 277, No. 44, pp. 42010-42016, Nov. 2002.
|
| 20 |
G. B. Moore, H. Chapman, J. C. Holder, C. A. Lister, V. Piercy, S. A. Smith, and J. C. Clapham, "Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice", Biochemical and Biophysical Research Communications, Vol. 286, No. 4, pp. 735-741, Aug. 2001.
DOI
|
| 21 |
M. D. Wang, V. Franklin, M. Sundaram, R. S. Kiss, K. Ho, M. Gallant, and Y. L. Marcel. "Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages", The Journal of Biological Chemistry, Vol. 282, No. 31, pp. 22525-22533, Aug. 2007.
DOI
|
| 22 |
N. Wang, D. Lan, W. Chen, F. Matsuura, A. R. Tall, "The E3 ubiquitin ligases, HUWE1 and NEDD4-1, are involved in the post-translational regulation of the ABCG1 and ABCG4 lipid transporters", The Journal of Biological Chemistry, Vol. 290, No. 40, pp. 24604-24612, Oct. 2015.
DOI
|
| 23 |
M. Van Eck, J. Twisk, M. Hoekstra, B. T. Van Rij, C. A. Van der Lans, I. S. Bos, and et al. "Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver", The Journal of Biological Chemistry, Vol. 278, No. 26, pp. 23699-23705, Jun. 2003.
DOI
|
webmaster
